Depressive Disorders - Southern Africa

  • Southern Africa
  • Revenue in the Depressive Disorders market is projected to reach US$131.80m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.03%, resulting in a market volume of US$131.60m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$6,263.00m in 2024).
  • In relation to total population figures, per person revenues of US$31.44 are generated in 2024.

Key regions: India, Europe, Japan, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Depressive Disorders market in Southern Africa is experiencing significant growth due to a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in the region are shifting towards a greater awareness and acceptance of mental health issues, including depressive disorders. There is a growing recognition of the importance of mental wellbeing and an increased willingness to seek professional help for mental health conditions. This shift in customer preferences has led to an increased demand for treatments and therapies for depressive disorders.Trends in the market are also contributing to its development. The Southern African region has seen an increase in the availability and accessibility of mental health services, including specialized clinics and treatment centers. This has made it easier for individuals to seek help for depressive disorders and has contributed to the growth of the market.Additionally, there has been a rise in the use of telemedicine and online therapy platforms in Southern Africa. These platforms provide convenient and confidential access to mental health professionals, particularly in remote areas where access to in-person services may be limited. The use of technology in mental health care has been a significant trend globally, and its adoption in Southern Africa has further fueled the growth of the Depressive Disorders market.Local special circumstances in Southern Africa, such as high levels of poverty and unemployment, have also contributed to the development of the Depressive Disorders market. These socioeconomic factors can increase the prevalence of depressive disorders and create a greater need for treatment options. Furthermore, the stigma surrounding mental health issues in some communities has started to diminish, encouraging more individuals to seek help for depressive disorders.Underlying macroeconomic factors, such as population growth and urbanization, have also played a role in the development of the Depressive Disorders market in Southern Africa. As the population continues to grow and more people move to urban areas, there is an increased demand for mental health services to meet the needs of a larger population. Additionally, economic development has led to an increase in disposable income, allowing individuals to afford treatments and therapies for depressive disorders.In conclusion, the Depressive Disorders market in Southern Africa is growing due to shifting customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The increasing awareness and acceptance of mental health issues, the availability of mental health services, the use of technology in mental health care, socioeconomic factors, and population growth are all contributing to the development of the market.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)